EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives

Federico Monti, Federica Perazza iD, Laura Leoni, Bernardo Stefanini, Silvia Ferri, Francesco Tovoli iD, Guido Zavatta iD, Fabio Piscaglia iD, Maria Letizia Petroni iD, Federico Ravaioli iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179193 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Federico Monti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B, Fatty Liver. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD)—and its worse form, metabolic-associated steatohepatitis (MASH), characterised by inflammation and liver damage—corresponds to the liver’s involvement in metabolic syndrome, which constitutes an economic burden for healthcare systems. However, the biomolecular pathways that contribute to steatotic liver disease are not completely clear. Abnormalities of bone metabolism are frequent in people affected by metabolic liver disease, with reduced bone density and an increased risk of fracture. Receptor activator of NF-κB (RANK), receptor activator of NF-κB ligand (RANKL), and osteoprotegerin(OPG) are critical regulators of bone metabolism, performing pleiotropic effects, and may have potential involvement in metabolic disorders like MASLD, resulting in a topic of great interest and intrigue. This narrative review aims to investigate this potential role and its implications in MASLD development and progression and in hepatocellular carcinoma, which represents its worst complication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa BFatty LiverHumansSignal TransductionAnimalsBone DiseasesLiver NeoplasmsCarcinoma, HepatocellularLiver Diseases

Stichwörter der Autor:innen

bone metabolismchronic liver diseasemetabolic dysfunction-associated steatotic liver diseasemetabolic-associated steatohepatitisosteopeniaosteoporosisvitamin D

Substanzen

OsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa BTNFRSF11A protein, humanTNFRSF11B protein, humanTNFSF11 protein, human

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Department of Dietetics and Clinical Nutrition, Maggiore-Bellaria Hospital, Azienda Unità Sanitaria Locale (AUSL), 40138 Bologna, Italy.
  • Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Unit of Clinical Nutrition and Metabolism, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Federica Perazza, Francesco Tovoli, Guido Zavatta, Fabio Piscaglia, Maria Letizia Petroni, Federico Ravaioli

Zitieren

APA

Monti, F., Perazza, F., Leoni, L., Stefanini, B., Ferri, S., Tovoli, F., Zavatta, G., Piscaglia, F., Petroni, M. L., & Ravaioli, F. (2024). RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179193

Vancouver

Monti F, Perazza F, Leoni L, Stefanini B, Ferri S, Tovoli F, et al. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179193

BibTeX
@article{Monti2024,
  author = {Monti, Federico and Perazza, Federica and Leoni, Laura and Stefanini, Bernardo and Ferri, Silvia and Tovoli, Francesco and Zavatta, Guido and Piscaglia, Fabio and Petroni, Maria Letizia and Ravaioli, Federico},
  title = {RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179193}
}
Kostenlos starten →